Address

CMEA Capital
One Embarcadero Center
Suite 3250
San Francisco, CA 94111
United States

Open map


Recent investment activity

KANDO id: 29362

Corporate information

Founders
Also known as
CMEA Ventures
Chemical and Materials Enterprise Associates
Registration country

Funds managed

Fund Type Vintage Currency Committed capital
CMEA Ventures VI LP Venture

Funding rounds

Profile Country
Chevron Technology Ventures LLC (CTV) Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron

Top investment portfolio themes

Actual initial investment stage
N/A (2)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 56
Profile Country Date Funding
Apriso Corp Provider of enterprise software solutions N/A
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. N/A
Codexis Inc Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. Series D
Codexis Inc Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. N/A
Draths Corp N/A
InSound Medical Inc Medical device company focused on the development and sale of next generation hearing aid solutions. Series E
LiveOps Inc Series B
Luminus Devices Inc Development and manufacturing of high performance solid state light sources for a variety of illumination applications Series E
Quantum Dot Corp N/A
Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. N/A
Relypsa Inc Leads the discovery and development of new non-absorbed polymeric drugs Series A
Rigel Pharmaceuticals Inc N/A
Sanera Systems Inc Series A
Schooner Information Technology Inc Enterprise storage software company. Series B
SpikeSource Inc Open source focused, software certification company. Series C
Strix Systems Inc Series B
Strix Systems Inc N/A
Surgiquest Inc Developer, manufacturer and marketer of innovative access technology for minimally invasive surgery. N/A
Symwave Developer and marketer of high-performance analog/mixed-signal integrated circuits and system solutions. Series C
Symyx Technologies Develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications. N/A
Syrrx Inc Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma N/A
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series C
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series A
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series B
VasoNova Inc Leader in algorithm-based vascular navigation and measurement technology. Series B

Selected Products / Customers

Financials